Argentina | info:eu-repo/semantics/article
dc.creatorRodriguez, Juan Bautista
dc.date.accessioned2019-10-10T20:49:47Z
dc.date.accessioned2022-10-15T07:57:45Z
dc.date.available2019-10-10T20:49:47Z
dc.date.available2022-10-15T07:57:45Z
dc.date.created2019-10-10T20:49:47Z
dc.date.issued2001-04
dc.identifierRodriguez, Juan Bautista; Specific molecular targets to control tropical diseases; Bentham Science Publishers; Current Pharmaceutical Design; 7; 12; 4-2001; 1105-1116
dc.identifier1381-6128
dc.identifierhttp://hdl.handle.net/11336/85636
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4363020
dc.description.abstractChagas' disease or American trypanosomiasis is considered by the Word Health Organization to be one of the important tropical parasitic diseases worldwide together with malaria and schistosomiasis. The etiologic agent of this illness is the kinetoplastid protozoon Trypanosoma cruzi. The present chemotherapy for the treatment of Chagas' disease remains unsolved. The drugs currently in use are old, ineffective and toxic. Bearing in mind the metabolic differences between the parasite and the mammalian host, some attractive interesting molecular targets for drug design are presented.
dc.languageeng
dc.publisherBentham Science Publishers
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://www.eurekaselect.com/64963/article
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.2174/1381612013397555
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectTrypanosoma cruzi
dc.subjectChagas' disease
dc.subjectTropical diseases
dc.titleSpecific molecular targets to control tropical diseases
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución